Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyometrial Oxytocin in Elective Cesarean Delivery
NCT01252342Phase 4Withdrawn
- Sponsor
- University of Saskatchewan
- Start
- Aug 2011
- Primary completion
- Apr 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) and uterine atony (2 arms), sponsored by University of Saskatchewan. Primary endpoint: Uterine Tone. Planned start Aug 2011; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT01252342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252342.